Canada markets closed

Fusion Pharmaceuticals Inc. (FUSN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.7000-0.3300 (-6.56%)
At close: 04:00PM EST
4.9000 +0.20 (+4.26%)
After hours: 04:29PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close5.0300
Open4.9500
Bid4.7000 x 4000
Ask4.8900 x 3100
Day's Range4.5000 - 5.0100
52 Week Range4.5000 - 13.3600
Volume220,314
Avg. Volume32,595
Market Cap202.411M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.8250
Earnings DateNov. 10, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est19.20
  • CNW Group

    Fusion Pharmaceuticals To Present At The 2021 Jefferies London Healthcare Conference

    Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the Company will present at the 2021 Jefferies London Healthcare Conference. A recording of the presentation will be made available for on-demand viewing on Thursday, November 18, 2021 at 8:00am GMT. Presenting on behalf of Fusion will be Chief Executive Officer John Valliant, Ph.D.

  • CNW Group

    Fusion Pharmaceuticals Announces Third Quarter 2021 Financial Results and Clinical Program Update

    Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced financial results for the third quarter ended September 30, 2021 and provided an update on clinical and corporate developments.

  • CNW Group

    Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the compensation committee of the Company's Board of Directors granted stock option awards to purchase an aggregate of 90,400 shares of its common stock to one employee outside Fusion's 2020 Stock Option and Incentive Plan. The stock options were granted as an inducement material to the individual becoming an employe